Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Besifovir Formulations in Healthy Volunteers
NCT02300688Phase 1Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Dec 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of adefovir dipivoxil in Chronic Hepatitis B (CHB) (2 arms), sponsored by Ildong Pharmaceutical Co Ltd. Primary endpoints: Area Under the Curve to the last measurable concentration at 15 hours and Maximum Plasma Concentration at 15 hours. Started Dec 2014; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02300688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02300688.